CPT® Code 88239

The CPT® Code 88239 refers to a laboratory procedure known as tissue culture for neoplastic disorders, specifically focusing on solid tumors. This procedure involves the cultivation of cells and/or tissue samples that are suspected to be involved in neoplastic disorders, which are conditions characterized by the abnormal growth of cells, often leading to tumors. The primary objective of this test is to analyze the genetic material within these cells to identify various chromosomal abnormalities, hereditary genotypes, mutations, phenotypes, and karyotypes. Such analyses are crucial for diagnosing neoplastic conditions, determining the prognosis of the disease, and monitoring the progression or response to treatment of hematopoietic diseases, which affect blood-forming tissues. To perform this test, whole blood is typically collected through a venipuncture, which is a separately reportable procedure. Additionally, bone marrow samples can be obtained via aspiration, also a separately reportable procedure. For solid tumors, tissue samples such as those from lymph nodes are acquired through excision or biopsy methods. The laboratory utilizes specific staining techniques, such as Giemsa Band, to evaluate whole blood and solid tissue samples. In the case of bone marrow, testing may involve Giemsa Band or advanced techniques like cell culture fluorescence in situ hybridization, which allows for detailed visualization of genetic material. This comprehensive approach ensures that healthcare providers have the necessary information to make informed decisions regarding patient care and treatment strategies.